Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Pancreatic Neoplasms 8Unspecified Adult Solid Tumor, Protocol Specific 1Resectable Pancreatic Carcinoma 1Resectable Pancreatic Cancer 1Rectal Neoplasms 1Prostatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Multiple Myeloma 1Leukemia, Myelomonocytic, Chronic 1Leukemia 1Breast Neoplasms 1Anemia, Refractory, with Excess of Blasts 1Anemia, Refractory 1Adenocarcinoma of the Pancreas 1Adenocarcinoma 1

Interventions

Cyclophosphamide 27fludarabine phosphate 21Cyclosporine 19Mycophenolic Acid 16Busulfan 16Cord Blood Stem Cell Transplantation 15Antilymphocyte Serum 14Whole-Body Irradiation 13Radiotherapy 13Peripheral Blood Stem Cell Transplantation 11Methylprednisolone 9Filgrastim 7Methotrexate 6Melphalan 6Tacrolimus 5fludarabine 4Thiotepa 4Etoposide 4Cytarabine 4sargramostim 3Granulocyte Colony-Stimulating Factor 3Cyclosporins 3Azacitidine 3Decitabine 2Arsenic Trioxide 24-phenylbutyric acid 2vatalanib 1poly ICLC 1paricalcitol 1lintuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Anemia, Refractory × paricalcitol × Clear all
NCT00064376 2018-01-29

Paricalcitol in Treating Patients With Myelodysplastic Syndrome

Cedars-Sinai Medical Center

Phase 2 Completed
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡